The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration adverse event reporting system (FAERS)
CONCLUSIONS: Using the Bradford Hill criteria however and taking into consideration confounders, no causal link between GLP-1 RAs and suicidality exists.PMID:38087976 | DOI:10.1080/14740338.2023.2295397
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Roger S McIntyre Rodrigo B Mansur Joshua D Rosenblat Angela T H Kwan Source Type: research
More News: Depression | Drugs & Pharmacology | European Medicines Agency (EMA) | Suicide | USA Health | Victoza